Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glucosaminyl transferase 1 pseudogene 4 (GCNT1P4) is classified as a pseudogene, meaning it is a region of DNA that resembles a functional gene but typically lacks the ability to encode a functional protein due to mutations or truncations in its sequence. Pseudogenes like GCNT1P4 may arise through gene duplication or retrotransposition, but they generally have no active role in cellular biology or pathology. GCNT1P4 is not considered a receptor, enzyme, transporter, transcription factor, or any other molecular target for pharmacological intervention. It neither participates in known biochemical pathways nor serves as a marker, and there are no drugs identified that interact with this pseudogene. The designation as "glucosaminyl transferase 1 pseudogene 4" suggests it is related by sequence to the functional glucosaminyl transferase 1 gene, but it does not encode a functional enzyme. If you are seeking information on a functional enzyme, the closely related active molecule is glucosaminyl (N-acetyl) transferase 1 (GCNT1), which is an actual enzyme involved in the biosynthesis of glycoproteins. For functional data—mechanism, disease relevance, targets, etc.—refer to the canonical enzyme (GCNT1) rather than this pseudogene. If you intended a drug target or functional protein, "GCNT1P4" is not correct for those purposes.
None; pseudogenes do not have mechanisms of action relevant to drug interaction
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glucosaminyl transferase 1 pseudogene 4 (GCNT1P4).